Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains.
about
Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytesTrafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalizationMolecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loopHIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptorsInhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptorCCR5 HIV-1 coreceptor activity. Role of cooperativity between residues in N-terminal extracellular and intracellular domainsEffects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccineThe HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cellsHIV-1 envelope determinants for cell tropism and chemokine receptor use.The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus.Identification of CXCR4 domains that support coreceptor and chemokine receptor functionsFrequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.Interference with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in primary T lymphocytes.Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usageThe cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolatesConstrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.Viral exploitation and subversion of the immune system through chemokine mimicry.HIV envelope gp120 activates human arterial smooth muscle cells.Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domainsDistinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.The nectin-1alpha transmembrane domain, but not the cytoplasmic tail, influences cell fusion induced by HSV-1 glycoproteins.Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.Coreceptor usage and biological phenotypes of HIV-1 isolates.Chemokine receptors: emerging opportunities for new anti-HIV therapies.A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein.Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agentsTwo distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein.Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switchingThe trinity of the cortical actin in the initiation of HIV-1 infectionMultifaceted mechanisms of HIV-1 entry inhibition by human α-defensinThe leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells.
P2860
Q21245460-76EDA878-9FD2-4149-918E-B2895A02EB4DQ22010658-23C3357B-EA6C-4F29-ABD0-A664ED055E01Q24616040-AA1B1AA5-AE62-4A9A-BE15-7425E7E2FFAFQ24682714-573735D5-6B25-4211-B2AC-E8CC25164572Q28343496-152500D1-8FFF-42D0-9753-8E631B52BE9FQ28379187-1821660D-7525-49AD-B7A5-B49C6CA5EB35Q28646662-5FB7B1D3-FFA0-48EF-A603-6AEB3D57242CQ29622903-8BBADA0B-6578-4ACB-857C-84151B232BABQ30760711-6CF414B6-FC4B-42DC-A225-74A53480F2DFQ33511958-7777D7CD-615C-413F-A13B-31374AFF3748Q33637946-01D420CD-4587-41FF-9A8C-BA5933364680Q33637951-768E99FF-95AC-4F4F-8895-AC9829E48D54Q33643223-F78EE4AB-56B1-4050-96B5-FC127ED6774EQ33647187-6F0F1F4E-7634-48B7-A3DD-63E3198DEBA3Q33728885-BFBF4F29-167F-4BD0-A7BD-BDECE72B5DCDQ33782007-8F4FB9DE-3993-4DFE-BBDC-0901735CD0B6Q33782165-7DD9C93C-0A8C-4830-BFAC-55B826A723EEQ33782296-386F3DAD-EEB5-436E-A2A4-B9A6C394F11FQ33782350-0C04F856-911C-45DC-805F-5B4952C8E0DFQ33797534-6820F19A-23C8-4880-9D93-438EA159D2AEQ33804016-20AACAA3-10A7-471B-842A-6FC1DCF6DD71Q33817249-A1B3119B-617B-4C40-9DA1-183EA14F7F72Q33857491-571EB413-C5A1-40EF-93A5-39FA219FF3A6Q33886716-7F3E5CD3-F966-4082-84AE-7FC813E5DAEBQ33933260-30613ECC-DDE4-4FEC-A83C-985A45086A2CQ33943009-157FBF27-13EC-4A57-B47A-C992A0CEB7F7Q34045610-95E3A255-04B6-45FD-B6D5-01FE7925A1FEQ34055508-AD10D7C8-78F0-483D-BEC2-C9F447D0C131Q34333583-B341DA97-67EE-404E-98A2-B710D2BD0DC7Q34465007-06342303-454D-453E-9D68-DEBA68C66B10Q34999203-4DDA52E1-C500-429B-ACA3-6B4CA519FDFEQ35050395-A022E031-31AA-43E8-BE96-597AA9B8334BQ35140318-E233DE79-D829-404B-9062-FBAD43742EA4Q35603419-B68C262A-3783-434A-B04C-2890452D65D2Q35890885-47309381-409E-49E6-ADA2-2EFDDF5FC6A9Q35898388-F5F57661-FE25-42A0-A6D4-DC654CC41B3EQ35947621-BB70797E-F382-41A6-9845-6DBE1CF49A59Q36156531-C93A758A-47B6-4DAD-B2F3-5C909D0B2668Q36217242-97C42EC7-ADBD-474B-BDD9-0F460DF7B02CQ36264736-72A8880F-5C85-4C29-A148-3C93A07FE27B
P2860
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Evolution of HIV-1 coreceptor ...... stinct CCR5 and CXCR4 domains.
@ast
Evolution of HIV-1 coreceptor ...... stinct CCR5 and CXCR4 domains.
@en
type
label
Evolution of HIV-1 coreceptor ...... stinct CCR5 and CXCR4 domains.
@ast
Evolution of HIV-1 coreceptor ...... stinct CCR5 and CXCR4 domains.
@en
prefLabel
Evolution of HIV-1 coreceptor ...... stinct CCR5 and CXCR4 domains.
@ast
Evolution of HIV-1 coreceptor ...... stinct CCR5 and CXCR4 domains.
@en
P2093
P2860
P356
P1476
Evolution of HIV-1 coreceptor ...... stinct CCR5 and CXCR4 domains.
@en
P2093
J D Turner
J F Berson
S C Peiper
P2860
P304
P356
10.1073/PNAS.94.12.6426
P407
P577
1997-06-01T00:00:00Z